再生元制药20250430

Good morning, good afternoon, and good evening to everyone listening around the world. Thank you for your interest in Regeneron and welcome to our first quarter 2025 earnings conference call. An archive and transcript of this call will be available on Regeneron's investor relations website shortly after the call ends. Joining me on today's call are Dr. Leonard Schleifer, board co-chair, co-founder, president, and chief executive officer, Welcome to the Regeneron Pharmaceuticals first quarter 2025 earnings c ...